Search Results

Independent Director since 2019

Independent Director since 2023

Independent Director since 2019

Independent Director since 2018

Independent Director since 2015

Joseph J. Wolk (Joe) is the Executive Vice President and Chief Financial Officer for Johnson & Johnson. Joe serves as a member of the company’s Executive Committee, playing a strategic role in the overall management of the organization and leading the development and execution of the business’ global long-term financial strategy. Additionally, as the financial steward of Johnson & Johnson, Joe’s scope of responsibilities includes driving competitive and profitable growth, generating sustainable cash flow, allocating capital to maximize value creation and managing risk across the entire enterprise.

Kathryn E. Wengel (Kathy) is Executive Vice President, Chief Technical Operations & Risk Officer for Johnson & Johnson, and a member of the Company’s Executive Committee. She has significant healthcare, operations and global business expertise – with more than three decades of experience in leadership positions at Johnson & Johnson.

Jennifer L. Taubert is Executive Vice President and Worldwide Chairman, Innovative Medicine at Johnson & Johnson, the world’s largest healthcare company. She is a member of the Corporation’s Executive Committee and leads the Innovative Medicine Group Operating Committee.

Jim Swanson is a global business and technology leader and Executive Vice President, Chief Information Officer, and member of the Executive Committee for Johnson & Johnson.

John C. Reed, M.D., Ph.D. is Executive Vice President, Pharmaceuticals, R&D and Johnson & Johnson (J&J) Executive Committee member, John believes there is no limit to what science can do to advance medicine and restore health.